Program: Scientific Workshops @ ASH
Session: CAR-T and Other Cellular Therapy for Mutiple Myeloma
Session: CAR-T and Other Cellular Therapy for Mutiple Myeloma
Thursday, December 3, 2020, 9:12 AM-9:57 AM
Disclosures: Maus: kite: Consultancy, Research Funding; century therapeutics: Current equity holder in private company; tcr2: Consultancy, Current equity holder in publicly-traded company; Novartis: Consultancy, Research Funding; arcellx: Consultancy, Research Funding.
See more of: CAR-T and Other Cellular Therapy for Mutiple Myeloma
See more of: Scientific Workshops @ ASH
See more of: Scientific Workshops @ ASH